Listed on GrantGunner. Last checked 20 May 2026.
About this grant
A 3-month hybrid accelerator based in Basel, Switzerland, supporting early-stage healthtech and techbio startups that accelerate pharma R&D. The program is equity-free and fee-free, offering mentorship, access to pharma experts, and post-program support including up to CHF 50K cash grant and up to CHF 50K services.
Who can apply
Early-stage healthtech and techbio startups (Pre-Seed to Series A, <$10M dilutive funding raised) building solutions for pharma R&D and looking to collaborate or partner with pharmaceutical companies.